Evidence-Based Laboratory Medicine for Cardiovascular Disease Management in Mental Healthcare: A Literature Review

Bupe A Kyelu1, Phillip T Bwititi2, Sita Sharma3

  • 1School of Health, Psychology and Medical Sciences, Royal Darwin Hospital, University of Southern Queensland, Toowoomba, AUS.

Cureus
|June 17, 2026
PubMed

Insights

This review highlights a significant gap in evidence-based laboratory medicine for cardiovascular disease (CVD) management within mental healthcare. There is a critical need for more research on clinical laboratory testing, like whole blood viscosity, to improve CVD prevention and care in mental health settings.

Area of Science:

  • Integrative medicine
  • Cardiovascular medicine
  • Mental health research

Background:

  • Cardiovascular disease (CVD) is a significant comorbidity in mental health populations, necessitating cardiology referrals.
  • Pathophysiology of CVD involves blood flow issues, yet data on evidence-based cardiovascular medicine, including clinical laboratory testing like whole blood viscosity (WBV), is scarce in mental healthcare.

Purpose of the Study:

  • To assess the current level of evidence-based laboratory medicine (EBLM) practice for CVD management in mental healthcare.
  • To examine demography, CVD complications, management guidelines, and laboratory monitoring (WBV) within this context.

Main Methods:

  • Systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) approach.
  • Searched two databases (Our World in Data, PubMed) and grey literature for "CVD and mental health" data, focusing on demography, epidemiology, CVD, guidelines, and pathology.
  • Included empirical and non-empirical data meeting inclusion criteria.

Main Results:

  • Anxiety and depression represent a substantial burden (89.36%) of mental health issues.
  • Combined prevalence of anxiety and depression is 11.10% in Australia, higher in young/mid-adults (50% vs. global 39%).
  • Significant gaps identified in EBLM for CVD in mental healthcare, with a lack of management guidelines and limited research on WBV.

Conclusions:

  • There are critical knowledge and practice gaps in EBLM for managing CVD in mental healthcare settings.
  • The high prevalence of CVD risk factors in younger adults with mental health conditions warrants further investigation and early intervention strategies.
  • Further research is crucial to advance EBLM in cardiovascular preventive clinical practice for mental health populations.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...